https://sputnikglobe.com/20211105/us-has-secured-millions-of-doses-of-pfizers-experimental-covid-19-pill-biden-says-1090506256.html
US Has Secured Millions of Doses of Pfizer's Experimental COVID-19 Pill, Biden Says
US Has Secured Millions of Doses of Pfizer's Experimental COVID-19 Pill, Biden Says
Sputnik International
Pfizer has announced that its experimental oral treatment for COVID-19 cut hospitalisation and death by 89 percent, and said it will ask the US Food and Drug... 05.11.2021, Sputnik International
2021-11-05T15:09+0000
2021-11-05T15:09+0000
2021-11-05T15:33+0000
joe biden
us
pfizer
pill
covid-19
https://cdn1.img.sputnikglobe.com/img/07e5/0b/05/1090506835_0:0:3065:1725_1920x0_80_0_0_bb39c8d1c3f417dadbf991e46afb940d.jpg
The United States has secured millions of doses of Pfizer's experimental anti-viral pill for COVID-19, President Joe Biden announced on Friday.President Biden said a potential FDA greenlight for the pill could "dramatically reduce" the risk of being hospitalised or dying from coronavirus.The statement comes hours after Pfizer announced that it had developed an experimental antiviral oral treatment for coronavirus that can slash the risk of being hospitalised or dying from the virus by 89 percent if taken within three days of developing symptoms.In a study of more than 1,200 coronavirus patients with a higher-than-average risk of developing serious illness, people who took the pills were far less likely to be hospitalised than those who got placebo pills. According to the study's preliminary results, no one who took a real pill died, whereas 10 people who were given placebo pills succumbed to the virus.Pfizer chief executive Albert Bourla said that the data suggests the pill-based treatment, if approved, could "eliminate up to nine out of 10 hospitalisations".The pharmaceutical company plans to share the data with the US Food and Drug Administration (FDA) "as soon as possible" in a bid to have the pill authorised.Pfizer rival Merck's COVID-19 pill is already under review at the FDA after showing strong initial results. The UK became the first country to approve Merck's pill on Thursday. Britain has also procured 250,000 courses of Pfizer's experimental pill, hailing the trial's results as "incredible".
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
joe biden, us, pfizer, pill, covid-19
joe biden, us, pfizer, pill, covid-19
US Has Secured Millions of Doses of Pfizer's Experimental COVID-19 Pill, Biden Says
15:09 GMT 05.11.2021 (Updated: 15:33 GMT 05.11.2021) Being updated
Pfizer has announced that its experimental oral treatment for COVID-19 cut hospitalisation and death by 89 percent, and said it will ask the US Food and Drug Administration (FDA) for the pill to be granted emergency use authorisation.
The United States has secured millions of doses of Pfizer's experimental anti-viral pill for COVID-19, President Joe Biden announced on Friday.
"If authorised by the FDA we may soon have pills that treat the virus in those who become infected. We've already secured millions of doses. The therapy would be another tool in our toolbox to protect people from the worst outcomes of COVID".
President Biden said a potential FDA greenlight for the pill could "dramatically reduce" the risk of being hospitalised or dying from coronavirus.
The statement comes hours after Pfizer announced that it had developed an experimental antiviral oral treatment for coronavirus that can slash the risk of being hospitalised or dying from the virus by 89 percent if taken within three days of developing symptoms.
In a study of more than 1,200 coronavirus patients with a higher-than-average risk of developing serious illness, people who took the pills were far less likely to be hospitalised than those who got placebo pills. According to the study's preliminary results, no one who took a real pill died, whereas 10 people who were given placebo pills succumbed to the virus.
Pfizer chief executive Albert Bourla said that the data suggests the pill-based treatment, if approved, could "eliminate up to nine out of 10 hospitalisations".
The pharmaceutical company plans to share the data with the US Food and Drug Administration (FDA) "as soon as possible" in a bid to have the pill authorised.
Pfizer rival Merck's COVID-19 pill is already under review at the FDA after showing strong initial results. The UK became the first country to approve Merck's pill on Thursday. Britain has also procured 250,000 courses of Pfizer's experimental pill, hailing the trial's results as "incredible".
